leadf
logo-loader
viewEden Research PLC
(
AIM:EDEN
)

Eden Research receives label extension for sustainable pesticide in Portugal

The product can now be used on more types of fruit and vegetables

Eden Research PLC - Eden Research receives label extension for sustainable pesticide in Portugal

Eden Research PLC (AIM:EDEN) said that its biofungicide, Mevalone, has received authorisation for use on new crops in Portugal.

It will be used for the control of the disease Botrytis cinerea, a destructive fungal pathogen affecting many plant species.

READ: Eden Research secures partnership to market fungicide product in North Africa

This latest label extension adds strawberries, raspberries, blueberries, cranberries, kiwi, aubergines and peppers to the label, with product applications being permitted close to the point of harvest.

The Atlantic Ocean heavily influences the climate in Portugal, making large areas mild and moist for much of the year, which is beneficial for crops but also favours the development of fungal pathogens.

The country is in the top ten kiwi producers in the world and over 14,000 tonnes of strawberries are exported from Portugal on an annual basis.

The sustainable pesticides firm said that the use of Araw gives growers flexibility as it is free from residues, while it avoids product rejections by wholesalers and food retailers that can result from higher-than-allowed pesticide residue levels.

Eden's biofungicide product, which is known as Mevalone in much of Europe, is sold exclusively in Spain and Portugal by Eden's commercial partner, Sipcam Iberia and Portugal under the name Araw.

Sipcam has extensive experience with Araw and has recently supported significant label extensions in Spain.

Following approval, Sipcam will be able to expand the market for Araw across thousands of hectares of new high value crops.

Quick facts: Eden Research PLC

Follow
AIM:EDEN

Price: 8.8 GBX

Market Cap: £33.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Eden Research (LON: EDEN) Presenting at the Cenkos Growth & Innovation Forum...

Eden Research (LON: EDEN) Presenting at the Cenkos Growth & Innovation Forum - Tuesday 8th June 2021   Cenkos Growth & Innovation Forum - Tuesday 8th June 2021 Join Cenkos and Proactive at the Growth & Innovation Forum on Tuesday the 8th June 2021 from 9am onwards. Meet...

on 10/6/21

2 min read